Skip to content
Inceptive logo — Learn Life's Languages

Inceptive

Learn Life's Languages

Founded 2021 United States Palo Alto, United States 65 employees Series A Total: $120.00M Biotechnology, Life Sciences

General Information

Company Name Inceptive
Founded Year 2021
Location United States Palo Alto, United States
Employees 65
Industries Biotechnology, Life Sciences
Funding Stage Series A
Business Model B2B, SaaS, Platform
Revenue Model Licensing, Service Fee, Project Based
Social

BounceWatch is an independent company data service, not affiliated with Inceptive. To contact Inceptive, visit inceptive.life.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Inceptive compare?

A PDF of Inceptive and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Inceptive soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Inceptive

Inceptive, founded in 2021, positions itself at the forefront of the Biotechnology and Life Sciences industries with its innovative approach to crafting "Biological Software." Their mission, encapsulated by their slogan, "Learn Life's Languages," involves the creation of synthetic molecules capable of executing complex functions within biological systems. This groundbreaking approach aims to make previously unreachable medicines and biotechnologies accessible on a broader scale.

Supported by an antedisciplinary team, Inceptive is a magnet for scientists, ML researchers, engineers, and entrepreneurs eager to revolutionize how we understand and engage with biological processes. The recent $100.00M Series A investment on 07 September 2023, backed by prominent investors such as Obvious Ventures, Andreessen Horowitz/a16z, Nvidia, and Section 32, underscores its strong potential. Headquartered in the United States, the company is strategically poised for significant impact and growth in the evolving landscape of biotechnological innovation.

Business keywords: Biological Software, Synthetic Molecules, Rational Drug Design, Biotechnology Innovation, Machine Learning in Biology, RNA Molecule Design, High-throughput Experiments, Antedisciplinary Team, Novel Medicines, Deep Learning Applications, Entrepreneurial Science, Biomedical Research Tools

Services & Products

Extrapolation of Biological Data
Design of Novel Therapeutics
Custom Model Co-Design with Partners
Accelerated Drug Discovery Cycles

Target Customers

Pharmaceutical Companies Biotech Firms Drugmakers Research Institutions

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Series A $100.00M 4
Obvious Ventures, Andreessen Horowitz/ a16z +2
07 Sep 2023
Seed Round $20.00M -
01 Jan 2022

Inceptive Alternatives & Competitors

View All Alternatives
Inceptive vs
deepmirror
deepmirror United Kingdom

The foundation model for drug design

Pre-Seed
16 employees
Biotechnology, Life Sciences
Inceptive vs

High-fidelity DNA synthesis using enzymes

Series B
82 employees
Biotechnology, Health and Wellness
Inceptive vs

Building the next generation of gene therapies

Series C
30 employees
Biotechnology, Health Care

FAQ About Inceptive

Learn Life's Languages
Inceptive was founded in 2021.
Inceptive is headquartered in Palo Alto, United States.
Inceptive operates in Biotechnology and Life Sciences. Its work centres on Biological Software, Synthetic Molecules, Rational Drug Design and Biotechnology Innovation. Its customers include Pharmaceutical Companies, Biotech Firms and Drugmakers.
Inceptive has a B2B, SaaS and Platform business model. Its revenue comes from Licensing, Service Fee and Project Based.
Inceptive has approximately 65 employees.
Inceptive has completed 2 funding rounds, raising a total of $120.00M. The latest funding stage is Series A.
Inceptive offers: Extrapolation of Biological Data, Design of Novel Therapeutics, Custom Model Co-Design with Partners, Accelerated Drug Discovery Cycles.
Top alternatives and competitors to Inceptive include deepmirror, Ansa Biotechnologies, Inc., Affinia Therapeutics, Ailurus Bio, DeepDiveBio, Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Inceptive and deepmirror are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Inceptive, https://www.bouncewatch.com/company/inceptive, updated 28 January 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout